Newsletter Archive
-
06.20.26 -- FDA Codifies CMC Flexibility For CGTs, Assay Selection, And Comparing Analytical-Validation Guidelines
6/20/2026
06/20/26 Bioprocess Online Newsletter
-
06.19.26 -- STREAM Edition: Democratizing Digital Tools
6/19/2026
06/19/26 Bioprocess Online Newsletter
-
06.19.26 -- Inside AstraZeneca's Fully Electrified Cell Therapy Facility
6/19/2026
06/19/26 Bioprocess Online Newsletter
-
06.18.26 -- Scale Vaccine Production With Proven Cell Culture Solutions
6/18/2026
06/18/26 Bioprocess Online Newsletter
-
06.18.26 -- Where Does 3D-Printed Single-Use Tech Fit In The Development Pipeline?
6/18/2026
06/18/26 Bioprocess Online Newsletter
-
06.17.26 -- Tools And Technologies Enabling Next-Generation Cell Therapies
6/17/2026
06/17/26 Bioprocess Online Newsletter
-
06.17.26 -- Downstream Decisions To Maximize Viral Vector Yields And Reduce COGs
6/17/2026
06/17/26 Bioprocess Online Newsletter
-
06.16.26 -- Environmental Monitoring For GMP
6/16/2026
06/16/26 Bioprocess Online Newsletter
-
06.16.26 -- The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
6/16/2026
06/16/26 Bioprocess Online Newsletter
-
06.15.26 -- Reduce mAb Aggregates: Practical Strategies
6/15/2026
06/15/26 Bioprocess Online Newsletter